Kohn Florian P M, Hauslage Jens
1Department of Membrane Physiology (230b), Institute of Physiology, University of Hohenheim, Stuttgart, Germany.
German Aerospace Center (DLR), Institute of Aerospace Medicine, Gravitational Biology, Linder Hoehe Cologne, Germany.
NPJ Microgravity. 2019 Mar 6;5:5. doi: 10.1038/s41526-019-0064-5. eCollection 2019.
To realize long-term manned space missions, e.g. to Mars, some important questions about pharmacology under conditions of different gravity will have to be answered to ensure safe usage of pharmaceuticals. Experiments on the International Space Station showed that the pharmacokinetics of drugs are changed in microgravity. On Earth, it is well known that the incorporation of substances into cellular membranes depends on membrane fluidity, therefore the finding that membrane fluidity is gravity dependent possibly has effects on pharmacodynamics of hydrophobic and amphiphilic substances in microgravity. To validate a possible effect of gravity on pharmacodynamics, experiments have been carried out to investigate the incorporation of lidocaine into plain lipid membranes under microgravity conditions. In microgravity, the induced increase in membrane fluidity associated with lidocaine incorporation is smaller compared to 1 controls. This experiment concerning the gravity dependence of pharmacodynamics in real microgravity clearly shows that the incorporation of amphipathic drugs into membranes is changed in microgravity. This might have significant impact on the pharmacology of drugs during long-term space missions and has to be investigated in more detail to be able to assess possible risks.
为了实现长期载人太空任务,比如前往火星的任务,必须回答一些关于不同重力条件下药理学的重要问题,以确保药物的安全使用。国际空间站上的实验表明,药物的药代动力学在微重力环境下会发生变化。在地球上,众所周知,物质融入细胞膜取决于膜的流动性,因此膜流动性依赖于重力这一发现可能会对微重力环境下疏水性和亲水性物质的药效学产生影响。为了验证重力对药效学可能产生的影响,已经开展了实验,以研究在微重力条件下利多卡因融入普通脂质膜的情况。在微重力环境中,与利多卡因融入相关的膜流动性的诱导增加幅度与正常对照相比更小。这项关于实际微重力环境下药效学对重力依赖性的实验清楚地表明,两亲性药物在微重力环境下融入膜的情况会发生变化。这可能会对长期太空任务期间药物的药理学产生重大影响,必须进行更详细的研究,以便能够评估可能存在的风险。